Dr. Madhusmita Misra, M.D., M.P.H.
Claim this profileMassachusetts General Hospital
Studies Childhood Obesity
Studies Obesity
2 reported clinical trials
4 drugs studied
Affiliated Hospitals
Clinical Trials Madhusmita Misra, M.D., M.P.H. is currently running
Oxytocin
for Adolescent Obesity
This is a randomized, double blind, placebo-controlled study of the effects of intranasal oxytocin in youths with obesity, ages 12-18 years old. Subjects will be randomized to receive intranasal oxytocin or placebo (3 sprays per nostril, 4 times per day) for 12 weeks. Study visits include screening to determine eligibility, 2-part main study visits at baseline, week 8, and week 12, and safety check-in visits at weeks 1, and 4; phone calls at weeks 2, 6, and 10, with a safety follow-up visit 6 weeks after the last dose of study drug. Study procedures include appetite, behavioral, metabolic, and endocrine assessments.
Recruiting0 awards Phase 23 criteria
Estrogen Therapy
for Eating Disorders
This is a randomized, double blind, placebo-controlled study of the effects of transdermal estradiol versus placebo on cognitive flexibility, reward processing, and eating disorder pathology in hypoestrogenemic female adolescents and young adults (ages 14-35 years) with an eating disorder characterized by extreme dietary restriction and/or excessive exercise. Subjects will be randomized 1:1 to 12 weeks of transdermal estradiol with cyclic progesterone or placebo patches and cyclic placebo pills. Study visits include a screening visit to determine eligibility and visits at baseline, 8 weeks, and 12 weeks. Study procedures comprise behavioral, neuroimaging, and endocrine assessments.
Recruiting0 awards Phase 26 criteria
More about Madhusmita Misra, M.D., M.P.H.
Clinical Trial Related3 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Madhusmita Misra, M.D., M.P.H. has experience with
- Oxytocin Nasal Spray
- Placebo
- 17-β Estradiol Transdermal Patches With Cyclic Progesterone
- Placebo Patch And Pill
Breakdown of trials Madhusmita Misra, M.D., M.P.H. has run
Childhood Obesity
Oxytocin
Eating Disorder
Anorexia nervosa
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Madhusmita Misra, M.D., M.P.H. specialize in?
Madhusmita Misra, M.D., M.P.H. focuses on Childhood Obesity and Obesity. In particular, much of their work with Childhood Obesity has involved treating patients, or patients who are undergoing treatment.
Is Madhusmita Misra, M.D., M.P.H. currently recruiting for clinical trials?
Yes, Madhusmita Misra, M.D., M.P.H. is currently recruiting for 2 clinical trials in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Madhusmita Misra, M.D., M.P.H. has studied deeply?
Yes, Madhusmita Misra, M.D., M.P.H. has studied treatments such as Oxytocin nasal spray, Placebo, 17-β estradiol transdermal patches with cyclic progesterone.
What is the best way to schedule an appointment with Madhusmita Misra, M.D., M.P.H.?
Apply for one of the trials that Madhusmita Misra, M.D., M.P.H. is conducting.
What is the office address of Madhusmita Misra, M.D., M.P.H.?
The office of Madhusmita Misra, M.D., M.P.H. is located at: Massachusetts General Hospital, Boston, Massachusetts 02114 United States. This is the address for their practice at the Massachusetts General Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.